Supplemental Figure 3 from BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer

MLA

Arul M. Chinnaiyan, et al. Supplemental Figure 3 from BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1541-7786.22514314.v1.

APA

Arul M. Chinnaiyan, Felix Y. Feng, Shaomeng Wang, Nora M. Navone, Stephen R. Plymate, June Escara-Wilke, Ingrid J. Apel, Pranathi M. Krishnamurthy, Vijaya L. Dommeti, Kari Wilder-Romans, & Irfan A. Asangani. (2023). Supplemental Figure 3 from BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer. https://doi.org/10.1158/1541-7786.22514314.v1

Chicago

Arul M. Chinnaiyan, Felix Y. Feng, Shaomeng Wang, Nora M. Navone, Stephen R. Plymate, June Escara-Wilke, Ingrid J. Apel, et al. 2023. “Supplemental Figure 3 from BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer,” April. doi:10.1158/1541-7786.22514314.v1.